Routes and modes of administration of resorcinol and their relationship to potential manifestations of thyroid gland toxicity in animals and man

International Journal of Toxicology

Volumn 27, Issue 1, 2008, Pages 59-63

  Welsch, Frank ^a  

^a Orbitox   (United States)

Author keywords

1,3 Benzenediol; CAS no.108 46 3; m hydroxybenzene; Resorcinol; Thyroid gland

Indexed keywords

BENZENE DERIVATIVE; DRINKING WATER; RESORCINOL;

BIOAVAILABILITY; CONCENTRATION RESPONSE; DRUG ABSORPTION; ENDOCRINE FUNCTION; HUMAN; HYPEREMIA; HYPOTHYROIDISM; INFLAMMATION; LACTATION; LEG ULCER; LEG VARICOSIS; MEDICAL LITERATURE; MEDICAL RESEARCH; MYXEDEMA; NONHUMAN; PALATABILITY; PREGNANCY; REPRODUCTION; REPRODUCTIVE TOXICITY; SHORT SURVEY; SIDE EFFECT; SKIN ABSORPTION; SKIN DEFECT; SKIN FUNCTION; SKIN ULCER; SLOW RELEASE FORMULATION; THYROID DISEASE; THYROID FUNCTION; THYROID GLAND; THYROID TOXICITY; TOXICOKINETICS;

ANIMALS; BIOLOGICAL AVAILABILITY; HUMANS; RESORCINOLS; SKIN ABSORPTION; THYROID DISEASES;

ANIMALIA; RATTUS;

EID: 39749160930     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810701876687     Document Type: Short Survey

References (28)

1. Benfeldt, E., J. Serup, and T. Menne. 1999. Effect of barrier perturbation on cutaneous salicylic acid penetration in human skin: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Br. J. Dermatol. 140:739-748.
2. Berthezene, F., M. Fournier, E. Bernier, and R. Mornex. 1973. L'hypothyroidie induite par la resorcine: a propos de deux observations. Lyon Medical 230:319-323.
3. Boeck, C. 1915. Fall von tödlicher Resorzinvergiftung bei äusserlicher Anwendung des Mittels. Dermatol. Wschr. 60:449-453.
4. Bontemps, H., G. Besson, H. Bochaton, and F. Carpentier. 1995. Confusion after topical uses of resorcinol. Arch. Dermatol. 131:112.
5. Bull, G. M., and R. Fraser. 1950. Myxedema from resorcinol ointment applied to leg ulcers. Lancet 1:851-855.
6. Choksi, N. Y., G. Jahnke, C. St. Hilaire, and M. D. Shelby. 2003. Role of thyroid hormones in human and laboratory animal reproductive health. Birth Defects Res. Part B 68:479-491.
7. Cohen, D. E., and R. H. Rice. 2001. Toxic responses of the skin. In Casarett & Doull's toxicology, the basic science of poisons, 6th ed., ed. C. D. Klaassen, 653-671. New York: McGraw-Hill Medical Publishing Division.
8. Cosmetology Report. 1993. Anonymous; Reports of the Scientific Committee on Cosmetology. A11 Resorcinol. 54th Plenary Meeting of 10 December 1993; pp. 437-444.
9. CSTEE. 2003. Opinion of the scientific committee on toxicity, ecotoxicity and the environment (CSTEE) on "Two study reports on endocrine disrupters by WRc and BKH Consulting Engineers." European Commission, CSTEE 40th Plenary Meeting, 12-13 November.
10. Divi, R. L., and D. R. Doerge. 1994. Mechanism-based inactivation of lacotoperoxidase and thyroid peroxidase by resorcinol derivatives. Biochemistry 33:9668-9674.
11. Doniach, I., and J. Logothetopoulos. 1953. The goitrogenic action of resorcinol in rats. Br. J. Exp. Pathol. 34:146-151.
12. Guinet, P., J. Tourniaire, and J. O. Peyrin. 1967. Etude clinique et biologique d'un goitre a la resorcine. Ann. D'Endocrinol. 28:199-206.
13. Jahnke, G., N. Y. Choksi, J. A. Moore, and M. D. Shelby. 2004. Thyroid toxicants: Assessing reproductive health effects. Environ. Health. Perspect. 112:363-368.
14. Johnson, R. F., and A. K. Johnson. 1990. Light-dark cycle modualates drinking to homeostatic challenges. Am. J. Physiol. 259:R1035-R1104.
15. Kim, Y. C., and H. B. Matthews. 1987. Comparative metabolism and excretion of resorcinol in male and female F344 rats. Fundam. Appl. Toxicol. 9:409-414.
16. Klem, A. 1930. Acute medicinal resorcinol poisoning. Norsk Mag. Laegev. 91:849-850.
17. Kyrle, J. 1915. Beiträge zur Kenntnis der Resorzinvergiftung bei äusserer Anwendung des Mittels. Dermat. Zschr. 22:505.
18. Merker, P. C., D. Yeung, D. Doughty, and S. Nacht. 1982. Pharmacokinetics of resorcinol in the rat. Res. Comm. Chem. Pathol. Pharmacol. 38:367-388.
19. Maibach, H., and E. Patrick. 2001. Dermatotoxicology. In Principles and methods of toxicology, 4th ed., ed. A. W. Hayes, 1039-1084. Philadelphia: Taylor & Francis.
20. NTP. 1992. Toxicology and Carcinogenesis Studies of Resorcinol in F344 Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Technical Report Series No. 403.
21. Pascher, F. 1978. Systemic reaction to topically applied drugs. Int. J. Dermatol. 17:768-775.
22. Roberts, M. S., R. A. Anderson, J. Swarbrick, and D. E. Moore. 1978. The percutaneous absorption of phenolic compounds: The mechanism of diffusion across the stratum corneum. J. Pharm. Pharmacol. 30:486-490.
23. Spiteri, N. J. 1982. Circadian patterning of feeding, drinking and activity during diurnal food access in rats. Physiol. Behav. 28:139-147.
24. Strakosch, E. 1943. Studies on ointments. V. Ointments containing resorcinol. Arch. Dermatol. Syphilol. 48:393-399.
25. Welsch, F., M. D. Nemec, and W. B. Lawrence. 2006. Two-generation reproductive toxicity study of resorcinol in rats. 45th Annual Meeting, Society of Toxicology, March 5-9, 2006. Abstract 1244. The Toxicologist, supplement to Toxicol. Sci. 90(1).
26. Welsch, F., M. D. Nemec, and W.B. Lawrence. 2008. Two-generation reproductive toxicity study of resorcinol administered via drinking water to Crl:CDR (SD) rats. Int. J. Toxicol. 27, this issue.
27. WIL 455003. 2005. A drinking water two-generation reproductive toxicity study of resorcinol in rats. WIL Research Laboratories, Ashland, Ohio. Appendix G, p. 4565.
28. Yeung, D., S. Kantor, S. Nacht, and E. H. Gans. 1983. Percutaneous absorption, blood levels, and urinary excretion of resorninol applied topically in humans. Intl. J. Dermatol. 22:321-324.